Sort
10,766 grants matching “checkpoint inhibitor”
The structural function of ATR in development, oncogenesis and cancer therapy
$366,000Shan Zha · Columbia University Health Sciences · R01 · FY2021 · CA
53BP1-dependent pathway in DNA repair
$366,000Junjie Chen · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
$366,000Chunru Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$366,000Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2018 · CA
A novel pathway to overcome resistance to immunotherapy in melanoma
$366,000Diana Nora Vaz Saleiro · Northwestern University At Chicago · R01 · FY2025 · CA
53BP1-dependent pathway in DNA repair
$366,000Junjie Chen · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
The structural function of ATR in development, oncogenesis and cancer therapy
$366,000Shan Zha · Columbia University Health Sciences · R01 · FY2017 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$366,000Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2020 · CA
Project 3: The Functional Contribution of Tumor Immunity in PDAC
$365,868Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2016 · CA
Mechanisms of radioresistance and strategies for radiosensitization in OCCC
$365,811Guang Peng · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Mechanisms of radioresistance and strategies for radiosensitization in OCCC
$365,811Guang Peng · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Immunotherapeutic Modalities for K-ras Mutant Lung Cancer: Sex- and Cell Type-Specific Roles of IL-6/STAT3 signaling
$365,756Seyed Javad Mirhassani Moghaddam · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Regulation of p53 and Checkpoint Signaling by Chromium(VI)
$365,625Anatoly Zhitkovich · Brown University · R01 · FY2022 · ES
Project 3: Modulation of the head and neck tumor immune microenvironment by targeting the TAM family of receptors
$365,499Deric L Wheeler · University Of Wisconsin-Madison · P50 · FY2023 · CA
Project 3: Development of Novel Therapies and Biomarkers for TNBC Patients
$365,447Charles M Perou · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
Project 4: Activity of CAR T cell Therapy for Patients with Metastatic TNBC
$365,428Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
Genome-wide networks that modulate the T-lineage cell fate
$365,348Cornelis Murre · Research Inst Of Fox Chase Can Ctr · P01 · FY2016 · AI
Epigenetically Engineered Mouse Model for Lung Cancer Therapy
$365,308Lanlan Shen · Baylor College Of Medicine · R01 · FY2021 · CA
Targeting Wnt signaling in therapy-resistant ovarian cancer
$365,281Benjamin G Bitler · University Of Colorado Denver · R37 · FY2021 · CA
Development of cambinol analogues as antilymphoma agents
$365,200Antonio Bedalov · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
Development of cambinol analogues as antilymphoma agents
$365,200Antonio Bedalov · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA
Development of cambinol analogues as antilymphoma agents
$365,200Antonio Bedalov · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Dual-pronged nano-drug delivery using plant virus-like particles
$365,157Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2023 · CA
STING Activating Synthetic Nanovaccine for HPV-Induced Cancers
$365,135Jinming Gao · Ut Southwestern Medical Center · R01 · FY2019 · CA
Robust-to-fragile transitions of a phase-separated mitotic organelle in triple-negative breast cancer
$365,063P. Todd Stukenberg · University Of Virginia · U54 · FY2025 · CA